George B. Abercrombie - Sep 10, 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Sep 10, 2021
Transactions value $
-$913,950
Form type
4
Date filed
9/14/2021, 04:14 PM
Previous filing
Jul 19, 2021
Next filing
Sep 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Options Exercise $18.8K +11K +366.67% $1.71 14K Sep 10, 2021 Direct
transaction BCRX Common Stock Options Exercise $96.6K +30K +214.29% $3.22 44K Sep 10, 2021 Direct
transaction BCRX Common Stock Options Exercise $87.3K +30K +68.18% $2.91 74K Sep 10, 2021 Direct
transaction BCRX Common Stock Sale -$1.12M -74K -100% $15.09 0 Sep 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Automatic Stock Option Grant Options Exercise $0 -11K -100% $0.00* 0 Sep 10, 2021 Common Stock 11K $1.71 Direct
transaction BCRX Automatic Stock Option Grant Options Exercise $0 -30K -100% $0.00* 0 Sep 10, 2021 Common Stock 30K $3.22 Direct
transaction BCRX Automatic Stock Option Grant Options Exercise $0 -30K -100% $0.00* 0 Sep 10, 2021 Common Stock 30K $2.91 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $14.87 to $15.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.